inactive mek1 (Carna Inc)
Structured Review

Inactive Mek1, supplied by Carna Inc, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/map2k1%5Binactive%5D/pmc12586182-54-6-8?v=Carna+Inc
Average 94 stars, based on 2 article reviews
Images
1) Product Images from "Combined cellular and biochemical profiling of Bruton’s tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers"
Article Title: Combined cellular and biochemical profiling of Bruton’s tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers
Journal: Frontiers in Oncology
doi: 10.3389/fonc.2025.1667291
Figure Legend Snippet: Kinase binding experiments and molecular docking of nemtabrutinib. Sensorgrams of nemtabrutinib and reference inhibitor binding in surface plasmon resonance experiments with MEK1 (a) or B-RAF (b) . The red and grey lines represent the experimental results and the black lines represent the fits obtained using a 1:1 binding model. (c) Binding mode of nemtabrutinib in the ATP-binding pocket of BTK (PDB ID: 6E4F). (d) Highest-scoring docking pose of nemtabrutinib in the ATP-binding pocket of MEK1 (PDB ID: 7XLP).
Techniques Used: Binding Assay, SPR Assay